A major component to successfully establish radioligand therapy
Tackling the Last Mile: A major component to successfully establish [...]
Happy New Year !
From all of us at the Oncidium foundation to you [...]
European Commission approves Pluvicto™
European Commission Approves Pluvicto for PSMA-Positive mCRPC OncLive, Dec 14, [...]
Novel PET Agent to Identify Patients for Targeted Therapies
Novel PET Agent Effectively Detects Multiple Cancers, Identifies Patients for [...]
Quo Vadis, Teragnosis?
Vercher-Conejero JL. Quo Vadis, Teragnosis? Rev Esp Med Nucl Imagen [...]
The Cary M. Adams Fund
Improving access to radiotheranostics for cancer patients in the US [...]
Discover Our Youtube Channel
You want to learn more about radiotheranostics and you are [...]
New PET Tracer Shows Promise for NENs
New PET Tracer Shows Promise for uPAR-Targeted Therapy of Neuroendocrine [...]